Phase 1 data from Generate Biomedicines’ ongoing chronic obstructive pulmonary disease study demonstrated “rapid and sustained reductions” across four disease biomarkers. AI-driven Generate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results